SCHEMBL4236887

SCHEMBL4236887

Cc1nn(-c2ccc(C#N)cc2)c(C)c1COc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.49
NPC1 O15118 3/20 0.49
PKM P14618 1/20 0.49
AR P10275 1/20 0.49
CYP19A1 P11511 2/20 0.48
CHEK2 O96017 1/20 0.46
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
SLC34A1 Q06495 1/20 0.42
RAB9A P51151 2/20 0.42
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.40
NQO1 P15559 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KCNJ1 P48048 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4230013 0.89 PTGS2 (0.49) MAPTNPC1PKMARCYP19A1
SCHEMBL4233150 0.89 AR (0.60) MAPTNPC1ARCYP19A1ALDH1A1
SCHEMBL4237759 0.85 AR (0.56) MAPTNPC1ARCYP19A1ALDH1A1
SCHEMBL4233511 0.83 AR (0.70) ARKDM4ESLC34A1
SCHEMBL4232172 0.83 AR (0.54) MAPTARCYP19A1ALDH1A1KDM4E
SCHEMBL4239003 0.83 AR (0.54) NPC1PKMARCYP19A1ALDH1A1
SCHEMBL4234713 0.81 MAPT (0.54) MAPTARALDH1A1SLC34A1RAB9A
SCHEMBL4237455 0.81 AR (0.52) NPC1ARCYP19A1ALDH1A1SLC34A1
SCHEMBL4302858 0.80 AR (0.52) MAPTARCHEK2ALDH1A1SLC34A1
SCHEMBL4296323 0.80 AR (0.54) MAPTARALDH1A1KDM4ESLC34A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270361-A1 Substituted pyrazole derivatives and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-29 US disclosed
US-20090270361-A1 Substituted pyrazole derivatives and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-29 US disclosed
WO-2009119880-A1 SUBSTITUTED PYRAZOLE DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270361-A1 Substituted pyrazole derivatives and use thereof CBR3, CBR1, NOX5 MAPT 3590/4885NPC1 1077/4885PKM 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.